跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gemhope - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gemhope
Approved
STANDARD
Gemhope
Glenmark Generics S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5a8dfb677c470b67
Company
Glenmark Generics S.A.
Type
Standard
Approval Details
Approval Id
5a8dfb677c470b67
Drug Approval Philippines Name
Gemhope
Product Name
Gemhope
Registration Number
DRP-8099
Brand Name
Gemhope
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder For Injection (I. V. Infusion)
Dosage Strength
200 mg
Manufacturer
Glenmark Generics S.A.
Importer
Glenmark Philippines, Inc.
Distributor
Glenmark Philippines, Inc.
Issuance Date
27 April 2025
Expiry Date
04 September 2031
Pharmacologic Category
Antineoplastic (Pyrimidine analogue)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5a8dfb677c470b67
Type
Standard
Back to Philippines FDA Approvals